Whanin Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Whanin Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Bukwang Pharmaceutical Company Limited
sales of 150.74 billion Korean Won [US$133.41 million]
of which 100%
Myungmoon Pharmaceutical Company Limited
(140.14 billion Korean Won [US$124.02 million]
of which 97%
was Manufacture and Sale of Pharmaceuticals), and
JW Life Science Corp
(143.60 billion Korean Won [US$127.09 million]
During the year ended December of 2017, sales at
Whanin Pharmaceutical Company Limited were 147.95 billion Korean Won (US$130.94 million).
increase of 4.7%
versus 2016, when the company's sales were 141.38 billion Korean Won.